Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–22 of 22 results
Advanced filters: Author: Trisha Gura Clear advanced filters

  • Allan Bradley is to head the Sanger Centre, a powerhouse of the Human Genome Project. Trisha Gura asks how he will meet the challenges.

    • Trisha Gura
    News
    Nature
    Volume: 405, P: 389

  • The editorial review of scientific papers usually takes place behind closed doors, but could the process be improved by opening it up for all to see? Trisha Gura investigates.

    • Trisha Gura
    News
    Nature
    Volume: 416, P: 258-260

  • Jonathan Tilly defied decades of dogma by suggesting that women can make new eggs throughout their lives. Now some of his critics are taking a second look.

    • Trisha Gura
    News
    Nature
    Volume: 491, P: 318-320

  • A small Canadian institute is producing a disproportionate number of highly cited biology papers. Trisha Gura visited the Amgen Institute, to find out what its members are doing right.

    • Trisha Gura
    News
    Nature
    Volume: 411, P: 519-520

  • Small molecules that selectively disrupt the proteins encoded by individual genes could become powerful tools in functional genomics. Trisha Gura explores the nascent but highly promising field of chemical genetics.

    • Trisha Gura
    News
    Nature
    Volume: 407, P: 282-284

  • Experts in neuroscience, computing and education are coming together in a massive effort to put the way in which children are taught on a sounder scientific footing. Trisha Gura profiles this ambitious — some might say foolhardy — initiative.

    • Trisha Gura
    News
    Nature
    Volume: 435, P: 1156-1158

  • Entrepreneurs who made their fortunes in high technology are now giving money away to fund biomedical research. These new philanthropists are sending a breath of fresh air through the labs they support, says Trisha Gura.

    • Trisha Gura
    News
    Nature
    Volume: 410, P: 140-143

  • Evolutionary trees constructed by studying biological molecules often don't resemble those drawn up from morphology. Can the two ever be reconciled, asks Trisha Gura

    • Trisha Gura
    News
    Nature
    Volume: 406, P: 230-233

  • The microbes that inhabit the human mouth have a lot to say about one's general health. That's part of the motivation behind a massive new push to catalog these oral bacteria. Trisha Gura finds out why researchers believe that the study of saliva deserves more than just lip service.

    • Trisha Gura
    News
    Nature Medicine
    Volume: 14, P: 706-709

  • With its farm-scale trials of genetically modified crops, Britain has taken ecological studies of farming practices into new territory. But the trials are the focus of intense controversy. Trisha Gura spoke to the scientists involved.

    • Trisha Gura
    News
    Nature
    Volume: 412, P: 760-763

  • After decades of disappointment, antibodies are finally emerging as viable — if expensive — drugs. Trisha Gura finds biotech start-ups and pharmaceutical giants rushing to claim a piece of the action.

    • Trisha Gura
    News
    Nature
    Volume: 417, P: 584-586

  • A biological gagging order, used in the fight against viruses, could revolutionize our understanding of genetics and development. Trisha Gura listens in on the world of gene silencing.

    • Trisha Gura
    News
    Nature
    Volume: 404, P: 804-808

  • The Nobels mark their centenary this week. Their prestige is unquestioned, but does the way in which winners are selected reflect the way science is done in the twenty-first century? Trisha Gura investigates.

    • Trisha Gura
    News
    Nature
    Volume: 413, P: 560-564

  • The pharmaceutical industry is increasingly turning to academics to tackle the early stages of drug discovery.

    • Trisha Gura
    Special Features
    Nature
    Volume: 492, P: 143-145

  • Seminars on career alternatives and soft skills can provide crucial tips for advancement. But some workshops are more helpful than others.

    • Trisha Gura
    Special Features
    Nature
    Volume: 488, P: 419-420

  • Involving members of the public can help science projects — but researchers should consider what they want to achieve.

    • Trisha Gura
    Special Features
    Nature
    Volume: 496, P: 259-261

  • A Pennsylvania clinic working with Amish and Mennonite communities could be a model for personalized medicine.

    • Trisha Gura
    News
    Nature
    Volume: 483, P: 20-22

  • Off-label prescribing is a fundamental fact of life of healthcare systems, but the promotion of off-label uses by drug sponsors is a fundamental sin. Regulators, legislators and drug makers are wrestling to find the right balance.

    • Mark Ratner
    • Trisha Gura
    Special Features
    Nature Biotechnology
    Volume: 26, P: 867-875